Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women

Introduction: We evaluated effects of teriparatide (rDNA origin) injection [teriparatide, rhPTH (1–34), TPTD] on hip structure among a subset 558 postmenopausal women enrolled in the Fracture Prevention Trial. Methods: Patients were randomized to once-daily, self-administered subcutaneous injections...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone (New York, N.Y.) N.Y.), 2005-06, Vol.36 (6), p.948-958
Hauptverfasser:	Uusi-Rasi, Kirsti, Semanick, Lisa M., Zanchetta, Jose R., Bogado, Cesar E., Eriksen, Erik F., Sato, Masahiko, Beck, Thomas J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Biomechanics Biomechanics. Biorheology Body Weight - drug effects Bone Density - drug effects Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - pharmacology Bone Density Conservation Agents - therapeutic use Clinical trials Diseases of the osteoarticular system Double-Blind Method Female Femur - drug effects Femur - pathology Femur Neck - drug effects Femur Neck - pathology Fundamental and applied biological sciences. Psychology Hip structure analysis Humans Medical sciences Middle Aged Osteoporosis Osteoporosis, Postmenopausal - drug therapy Osteoporosis, Postmenopausal - pathology Osteoporosis. Osteomalacia. Paget disease PTH Teriparatide - administration & dosage Teriparatide - pharmacology Teriparatide - therapeutic use Tissues, organs and organisms biophysics Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!